Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raman Puri

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of the Association of Physicians of India|August 20, 2024
Navigating Cardiovascular Risk and Lipid Management in Indian Patients: Key Messages from the Lipid Association of India 2024 Consensus Statement IVRaman Puri, Vimal Mehta, Manish Bansal, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|December 29, 2025
A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9Pradeep Kumar, Sudesh Prajapathi, Abhishek Singh, et al.
Journal of Clinical Lipidology|September 15, 2024
Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT studyKunal Mahajan, Raman Puri, P Barton Duell, et al.
Journal of Clinical Lipidology|April 13, 2021
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid AssociationDinesh Kalra, Krishnaswami Vijayaraghavan, Geeta Sikand, et al.
Journal of the American Heart Association|July 14, 2025
Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian IndividualsDarshan Patel, Marlys L Koschinsky, Anandita Agarwala, et al.
The Journal of the Association of Physicians of India|March 12, 2026
Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS StudyVimal Mehta, Nikhil Agarwal, Pratishtha Mehra, et al.
Journal of Clinical Lipidology|February 12, 2020
Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center studyNitika Setia, Sireesha Movva, Prahlad Balakrishnan, et al.
JACC. Asia|June 30, 2026
Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide StudyRaman Puri, Manish Bansal, Kunal Mahajan, et al.
Journal of Clinical Lipidology|February 25, 2020
Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.
Global Heart|November 16, 2022
World Heart Federation Cholesterol Roadmap 2022Kausik K Ray, Brian A Ference, Tania Séverin, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of the Association of Physicians of India|August 20, 2024
Navigating Cardiovascular Risk and Lipid Management in Indian Patients: Key Messages from the Lipid Association of India 2024 Consensus Statement IVRaman Puri, Vimal Mehta, Manish Bansal, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|December 29, 2025
A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9Pradeep Kumar, Sudesh Prajapathi, Abhishek Singh, et al.
Journal of Clinical Lipidology|September 15, 2024
Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT studyKunal Mahajan, Raman Puri, P Barton Duell, et al.
Journal of Clinical Lipidology|April 13, 2021
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid AssociationDinesh Kalra, Krishnaswami Vijayaraghavan, Geeta Sikand, et al.
Journal of the American Heart Association|July 14, 2025
Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian IndividualsDarshan Patel, Marlys L Koschinsky, Anandita Agarwala, et al.
The Journal of the Association of Physicians of India|March 12, 2026
Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS StudyVimal Mehta, Nikhil Agarwal, Pratishtha Mehra, et al.
Journal of Clinical Lipidology|February 12, 2020
Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center studyNitika Setia, Sireesha Movva, Prahlad Balakrishnan, et al.
JACC. Asia|June 30, 2026
Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide StudyRaman Puri, Manish Bansal, Kunal Mahajan, et al.
Journal of Clinical Lipidology|February 25, 2020
Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.
Global Heart|November 16, 2022
World Heart Federation Cholesterol Roadmap 2022Kausik K Ray, Brian A Ference, Tania Séverin, et al.
Pageof 4